Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens-Reference-Cited by-同舟云学术

Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens

Published:2019-12 Issue:12 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kirby James E.¹²,Brennan-Krohn Thea¹²³,Smith Kenneth P.¹²

Affiliation:

1. Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

2. Harvard Medical School, Boston, Massachusetts, USA

3. Division of Infectious Diseases, Boston Children’s Hospital, Boston, Massachusetts, USA

Abstract

There are now several new antibiotics available to treat multidrug-resistant pathogens, and susceptibility testing methods for these drugs are increasingly available at the time of drug approval. However, lack of clarity regarding verification requirements remains a formidable barrier to introducing such testing in clinical laboratories, making these drugs practically unavailable for patient use.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01270-19

Reference8 articles.

1. The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?

2. Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls

3. Clark RB, Lewisnski ML, Loeffelholtz MJ, Tibbets RJ. 2009. Verification and validation of procedures in the clinical microbiology laboratory. In Sharp SE (ed), Cumitechs, vol 31A. American Society of Microbiology, Washington, DC.

4. FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements

5. Rapid Susceptibility Testing Methods

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to verify and validate a clinical microbiology test before it can be used in routine diagnostics: a practical guide;Clinical Microbiology and Infection;2024-10

2. Testing for SARS-CoV-2: lessons learned and current use cases;Clinical Microbiology Reviews;2024-06-13

3. Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens;Microbiology Spectrum;2024-06-04

4. Pathogens susceptible to tetracycline are also susceptible to omadacycline: tetracycline as a one-sided surrogate to predict omadacycline susceptible pathogens;Diagnostic Microbiology and Infectious Disease;2022-11

5. Early appropriate diagnostics and treatment of MDR Gram-negative infections;JAC-Antimicrobial Resistance;2022-09-05